Table of Contents

2019-2024 Global Oral OTC Analgesics Consumption Market Report

1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Oral OTC Analgesics Consumption 2014-2024
2.1.2 Oral OTC Analgesics Consumption CAGR by Region
2.2 Oral OTC Analgesics Segment by Type
2.2.1 Acetaminophen (TYLENOL)
2.2.2 Salicylates
2.2.3 Nonsteroidal Anti-inflammatory Drugs (NSAIDs)
2.3 Oral OTC Analgesics Consumption by Type
2.3.1 Global Oral OTC Analgesics Consumption Market Share by Type (2014-2019)
2.3.2 Global Oral OTC Analgesics Revenue and Market Share by Type (2014-2019)
2.3.3 Global Oral OTC Analgesics Sale Price by Type (2014-2019)
2.4 Oral OTC Analgesics Segment by Application
2.4.1 Retail Pharmacies
2.4.2 Hospital Pharmacies
2.4.3 Online Pharmacies
2.5 Oral OTC Analgesics Consumption by Application
2.5.1 Global Oral OTC Analgesics Consumption Market Share by Application (2014-2019)
2.5.2 Global Oral OTC Analgesics Value and Market Share by Application (2014-2019)
2.5.3 Global Oral OTC Analgesics Sale Price by Application (2014-2019)

3 Global Oral OTC Analgesics by Players
3.1 Global Oral OTC Analgesics Sales Market Share by Players
3.1.1 Global Oral OTC Analgesics Sales by Players (2017-2019)
3.1.2 Global Oral OTC Analgesics Sales Market Share by Players (2017-2019)
3.2 Global Oral OTC Analgesics Revenue Market Share by Players
3.2.1 Global Oral OTC Analgesics Revenue by Players (2017-2019)
3.2.2 Global Oral OTC Analgesics Revenue Market Share by Players (2017-2019)
3.3 Global Oral OTC Analgesics Sale Price by Players
3.4 Global Oral OTC Analgesics Manufacturing Base Distribution, Sales Area, Product Types by Players
3.4.1 Global Oral OTC Analgesics Manufacturing Base Distribution and Sales Area by Players
3.4.2 Players Oral OTC Analgesics Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 Oral OTC Analgesics by Regions
4.1 Oral OTC Analgesics by Regions
4.1.1 Global Oral OTC Analgesics Consumption by Regions
4.1.2 Global Oral OTC Analgesics Value by Regions
4.2 Americas Oral OTC Analgesics Consumption Growth
4.3 APAC Oral OTC Analgesics Consumption Growth
4.4 Europe Oral OTC Analgesics Consumption Growth
4.5 Middle East & Africa Oral OTC Analgesics Consumption Growth

5 Americas
5.1 Americas Oral OTC Analgesics Consumption by Countries
5.1.1 Americas Oral OTC Analgesics Consumption by Countries (2014-2019)
5.1.2 Americas Oral OTC Analgesics Value by Countries (2014-2019)
5.2 Americas Oral OTC Analgesics Consumption by Type
5.3 Americas Oral OTC Analgesics Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries

6 APAC
6.1 APAC Oral OTC Analgesics Consumption by Countries
6.1.1 APAC Oral OTC Analgesics Consumption by Countries (2014-2019)
6.1.2 APAC Oral OTC Analgesics Value by Countries (2014-2019)
6.2 APAC Oral OTC Analgesics Consumption by Type
6.3 APAC Oral OTC Analgesics Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries

7 Europe
7.1 Europe Oral OTC Analgesics by Countries
7.1.1 Europe Oral OTC Analgesics Consumption by Countries (2014-2019)
7.1.2 Europe Oral OTC Analgesics Value by Countries (2014-2019)
7.2 Europe Oral OTC Analgesics Consumption by Type
7.3 Europe Oral OTC Analgesics Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa
8.1 Middle East & Africa Oral OTC Analgesics by Countries
8.1.1 Middle East & Africa Oral OTC Analgesics Consumption by Countries (2014-2019)
8.1.2 Middle East & Africa Oral OTC Analgesics Value by Countries (2014-2019)
8.2 Middle East & Africa Oral OTC Analgesics Consumption by Type
8.3 Middle East & Africa Oral OTC Analgesics Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Oral OTC Analgesics Distributors
10.3 Oral OTC Analgesics Customer

11 Global Oral OTC Analgesics Market Forecast
11.1 Global Oral OTC Analgesics Consumption Forecast (2019-2024)
11.2 Global Oral OTC Analgesics Forecast by Regions
11.2.1 Global Oral OTC Analgesics Forecast by Regions (2019-2024)
11.2.2 Global Oral OTC Analgesics Value Forecast by Regions (2019-2024)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.5.6 Spain Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Oral OTC Analgesics Forecast by Type
11.8 Global Oral OTC Analgesics Forecast by Application

12 Key Players Analysis
12.1 Pfizer
12.1.1 Company Details
12.1.2 Oral OTC Analgesics Product Offered
12.1.3 Pfizer Oral OTC Analgesics Sales, Revenue, Price and Gross Margin (2017-2019)
12.1.4 Main Business Overview
12.1.5 Pfizer News
12.2 Bayer
12.2.1 Company Details
12.2.2 Oral OTC Analgesics Product Offered
12.2.3 Bayer Oral OTC Analgesics Sales, Revenue, Price and Gross Margin (2017-2019)
12.2.4 Main Business Overview
12.2.5 Bayer News
12.3 Novartis
12.3.1 Company Details
12.3.2 Oral OTC Analgesics Product Offered
12.3.3 Novartis Oral OTC Analgesics Sales, Revenue, Price and Gross Margin (2017-2019)
12.3.4 Main Business Overview
12.3.5 Novartis News
12.4 Johnson & Johnson
12.4.1 Company Details
12.4.2 Oral OTC Analgesics Product Offered
12.4.3 Johnson & Johnson Oral OTC Analgesics Sales, Revenue, Price and Gross Margin (2017-2019)
12.4.4 Main Business Overview
12.4.5 Johnson & Johnson News
12.5 GlaxoSmithKline
12.5.1 Company Details
12.5.2 Oral OTC Analgesics Product Offered
12.5.3 GlaxoSmithKline Oral OTC Analgesics Sales, Revenue, Price and Gross Margin (2017-2019)
12.5.4 Main Business Overview
12.5.5 GlaxoSmithKline News
12.6 Sanofi
12.6.1 Company Details
12.6.2 Oral OTC Analgesics Product Offered
12.6.3 Sanofi Oral OTC Analgesics Sales, Revenue, Price and Gross Margin (2017-2019)
12.6.4 Main Business Overview
12.6.5 Sanofi News
12.7 Reckitt Benckiser
12.7.1 Company Details
12.7.2 Oral OTC Analgesics Product Offered
12.7.3 Reckitt Benckiser Oral OTC Analgesics Sales, Revenue, Price and Gross Margin (2017-2019)
12.7.4 Main Business Overview
12.7.5 Reckitt Benckiser News
12.8 Takeda Pharmaceutical Company
12.8.1 Company Details
12.8.2 Oral OTC Analgesics Product Offered
12.8.3 Takeda Pharmaceutical Company Oral OTC Analgesics Sales, Revenue, Price and Gross Margin (2017-2019)
12.8.4 Main Business Overview
12.8.5 Takeda Pharmaceutical Company News
12.9 Sun Pharmaceutical Industries
12.9.1 Company Details
12.9.2 Oral OTC Analgesics Product Offered
12.9.3 Sun Pharmaceutical Industries Oral OTC Analgesics Sales, Revenue, Price and Gross Margin (2017-2019)
12.9.4 Main Business Overview
12.9.5 Sun Pharmaceutical Industries News

13 Research Findings and Conclusion